Exact Sciences Corp (EXAS) Posts Wider than Expected Q1 Loss of 19c/Share

Exact Sciences Corp (NASDAQ: EXAS) reported Q1 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $1.04 million versus the consensus estimate of $1.03 million.

For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Pfizer lung cancer drug misses survival goal in Phase 3 trial